Apollo Endosurgery develops devices that advance therapeutic endoscopy, focusing on alternatives to invasive surgical procedures to improve patient lives.

Apollo Endosurgery

Apollo Care

IPhone / Mobile Compatible

Viewport Meta

Google Tag Manager

HSTS

Google Font API

DNSSEC

WordPress

Amazon

LetsEncrypt

Cloudflare CDN

President and CEO

Chas McKhann

Chief Medical Officer

Christopher J. Gostout

Chief Financial Officer

Jeffrey Black

Stefanie Cavanaugh

Vice President Business Process and Systems

Boris Fischer

Vice President, US Sales

Bret Schwartzhoff

Vice President, Legal and Compliance

Brian Szymczak

Vice President- Quality and Regulatory Affairs

David Hooper

Executive Vice President, Operations

John Molesphini

Vice President of US Sales

Kirk Ellis

Bruce Robertson

Jack Nielsen

John Creecy

David M. Hooper

Keely Scamperle

VP of Reimbursement & Market Access

Pankaj Pasricha

Co-founder

Southern US Acquired Companies (Top 10K)

Medical Device Acquired Companies With More Than 50 Employees

Medical Device Acquired Companies

Southern US Companies that Exited (Top 10K)

Apollo Endosurgery develops medical devices for the diagnosis and treatment of gastrointestinal diseases. The company’s device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo’s products include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.

Apollo Endosurgery was founded upon the initial work of the Apollo Group, an international think tank of world-renowned gastroenterologists and surgeons from five leading universities (Mayo Clinic, Johns Hopkins, Medical University of South Carolina, University of Texas Medical Branch-Galveston and Chinese University-Hong Kong.)  Disappointed with the pace of innovation in therapeutic flexible endoscopy, the Group assembled in 1998 (Timeline) with the goal to advance the new discipline; their specific focus was the use of long, flexible instruments deployed through a natural orifice in order to diagnose and potentially treat gastrointestinal disorders.

Innovatus Capital Partners

Post-IPO Debt - Apollo Endosurgery

Post-IPO Equity - Apollo Endosurgery

Craig-Hallum Capital Group

PTV Healthcare Capital

Convertible Note - Apollo Endosurgery

Debt Financing - Apollo Endosurgery

UT Horizon Fund

Series C - Apollo Endosurgery

Private Equity Round - Apollo Endosurgery

Venture Round - Apollo Endosurgery

Austin

Texas

United States

North America

The biggest medtech personnel moves of 2023

$407.6+ Million Obesity Intervention Devices Market to Grow ...

Top Research Reports for Visa, AbbVie & BHP

Surgical fastener deployment system

Endoscopic needle assembly

Surgical Sutures Market Projected to Achieve 5.6% CAGR ...

Boston Scientific (BSX) Expands Globally Amid FX Concerns

Endoscopic suture loop anchors and methods

Designed for adults with obesity to reduce stomach volume and slow food passage through the stomach, requiring a healthy lifestyle for effectiveness.

A temporary weight loss aid for adults suffering from obesity, involving a saline-filled balloon placed in the stomach to reduce food intake.

Facilitates weight loss by reducing stomach size and slowing food passage, intended for adults with obesity who have had previous bariatric procedures.

Allows physicians to place full-thickness sutures through a flexible endoscope for a range of less invasive gastrointestinal procedures.

Enables suture-based closure of large or irregular shaped defects in the gastrointestinal tract through standard endoscopic equipment.

Philippines

Asia

India

Bangladesh

Costa Rica

HTML5

Lightbox

F5 NGINX

Modernizr

DigiCert

Google Fonts

Wordpress

Vimeo

Office 365

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 29, 2024 7:49 PM	23175bd2
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Sep 30, 2024 6:17 PM	00b02db3
company summary	general
signals	general	Sep 29, 2024 7:49 PM	3ab2f253
crunchbase trigger	general	Nov 27, 2024 12:50 PM	acb4e7cd
crunchbase profile	general	Nov 28, 2024 8:41 AM	53c44a66
li profile	general
translate crunchbase fundingrounds	general	Nov 28, 2024 9:14 AM	ffb77622
peers	general	Sep 29, 2024 7:49 PM	7a04d8a6
news basic	general	Sep 29, 2024 7:49 PM	635ccd52
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:APOLLOENDO

Apollo Endosurgery